Related Experiment Video
Updated: Jul 15, 2025

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases
Published on: September 6, 2024
Structural and dynamic changes in P-Rex1 upon activation by PIP3 and inhibition by IP4
Sandeep K Ravala1, Sendi Rafael Adame-Garcia2, Sheng Li3
1Departments of Biological Sciences and of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana 47907, United States.
Inositol tetraphosphate (IP4) inhibits P-Rex1 activity by stabilizing an autoinhibited conformation. This discovery reveals a novel regulatory mechanism for P-Rex1, crucial for neutrophil function and cancer metastasis.
Area of Science:
- Biochemistry
- Cell Biology
- Structural Biology
Background:
- P-Rex1 is a guanine-nucleotide exchange factor (GEF) vital for neutrophil chemotaxis and cancer metastasis.
- P-Rex1 is activated by PIP3 and Gβγ subunits, but its precise regulation is not fully understood.
Conclusions:
- IP4 acts as a negative regulator of P-Rex1, contributing to basal inhibition in neutrophils.
- The P-Rex1·IP4 structure represents a key autoinhibited state, providing insights into GEF regulation.
- Understanding P-Rex1 inhibition is critical for targeting neutrophil function in inflammation and cancer.
More Related Videos
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
IP3/DAG Signaling Pathway
The JAK-STAT Signaling Pathway
Regulation of the Unfolded Protein Response
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

